search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
3 TO BE INCLUDED IN OUR NEXT ISSUE, SEND ALL YOUR RESEARCH AND EVENTS NEWS STORIES TO HEATHER@INTLABMATE.COM


15th Joint Fera/JIFSAN Annual Symposium:


Emerging Issues in Food Safety The Symposium will cover the latest and potential challenges threatening the safety, sustainability and integrity of the supply chain. It is purposely highly topical and forward- looking, selected in light of recent, largely un-anticipated, high profi le incidents which have impacted the global food industry, consumer confi dence, and placed all involved in the food supply chain under increasingly intense scrutiny. Under the spotlight will be instrumental methods of analysis;


MEDICA 2013 Report


Good international business contacts are becoming increasingly important for manufacturers of medical technology and medical products. Only those that are well- positioned at the international level are able to balance weaknesses in individual markets and profi t in the long run from a market that, seen globally, is growing.


That is the key message conveyed after four days of events (20-23 November 2013) at MEDICA 2013, the world’s largest medical trade fair, and COMPAMED 2013 (20–22 November 2013), the leading trade fair for the supplier market for medical technology manufacturing.


More than half of the 132,000 trade visitors (2012: 130,600) came from more than 120 countries. From the 4,641 exhibitors representing 66 countries, visitors obtained information on the entire spectrum of new products for high-quality, effi cient medical care – ranging from medical technology and electromedicine, laboratory technology, physiotherapy products and orthopaedic technology to health IT.


Date of the next MEDICA Düsseldorf: 12-15 November 2014 Date of the next COMPAMED in Düsseldorf: 12-14 November 2014.


28485pr@reply-direct.com


CTA Workshop – STFC Daresbury 20 March 2014 CTA research and industry.


The STFC Innovations Club are hosting an event on the Cherenkov Telescope Array (CTA) to discuss current developments and future R&D needs in the key areas of CTA, the largest and most sensitive gamma-ray telescope in the world to be built on two sites, one in the northern hemisphere and one in the south.


This workshop aims to pull together the interest from both the academia and industry in order to facilitate knowledge exchange (KE) between STFC- funded researchers working on CTA and industry with a view to exploiting synergies between


The workshop will further highlight funding opportunities to support KE relationships around the CTA project as well as provide an opportunity to hear a general update on the status of CTA and the anticipated UK role in the project. In addition there will be a poster session detailing industry relevant work carried out by the university research groups.


For more details visit www.eventbrite.co.uk (CTA workshop –STFV). 28488pr@reply-direct.com


emerging sciences; developments in ‘horizon scanning’; and recent food incidents. The symposium will tackle the way that regulators, researchers and industry can work together to assess, monitor, manage and mitigate the impact of food scares on global economies, industry, and consumer safety and confi dence.


28127pr@reply-direct.com


PITTCON 2014


Chicago, Illinois, USA 2-6 March 2014 If you are a scientist looking for the latest in laboratory equipment— then Pittcon 2014, the


world’s largest annual conference and exposition for laboratory science,


is a must attend event! See all the innovations in instrumentation from leading companies from around the world, learn about the latest techniques used in your industry, select from over 2,000 technical sessions and over 100 short courses, and participate in networking opportunities with world renowned scientists.


www.pittcon.org ARABLAB Dubai International Convention


& Exhibition Centre 17-20 March 2014 ARABLAB is the only trade show for the Analytical Industry that reaches buyers from the


growth markets such as the Middle East & Africa and the Indian Sub-Continent as well as China & Asia.


www.arablab.com


ANALYTICA 2014 Munich, Germany 1-4 April 2014


Protein to Combat Prostate Cancer Cell Growth


Researchers from Imperial College London and the University of Essex, have been testing a ‘designer’ protein that could be effective at treating prostate cancer, which has the ability to grow when they are exposed to male hormones such as testosterone and bind to specifi c receptors. The research team has been working on combining two separate proteins to create a hybrid, with one half binding to the receptor, whilst the other half blocks the receptor’s activity. The research demonstrates that both of these factors are important in blocking activity, and consequently the growth of the cancer.


Dr Charlotte Bevan, senior author of the study, from the Department of Surgery and Cancer at Imperial College London said: “Our team is seeking to design a new therapy that will help patients once the other ones have failed. There is a lot of research supporting the idea that the androgen receptor continues to drive prostate cancer growth, so we have been investigating novel methods to block this pathway.”


“So far, the research has only been carried out in prostate


cancer cells in the laboratory. These proof of principle experiments are really promising, but more work is needed before these therapies are ready for clinical trials,” said Dr Greg Brooke, fi rst author of the study, now at the School of Biological Sciences, University of Essex. “The next step is to continue research in cell models to refi ne the therapy into something that is specifi c, potent and easy to deliver. It’s exciting to think that this research could offer new hope for men with advanced prostate cancer.”


They hope to develop the protein into a therapeutic that could be trialled in patients within fi ve years.


This work was supported by Prostate Cancer UK (formerly Prostate Action), The Martin Harris Research Fellowship, Imperial Innovations and Johnson & Johnson Services Inc, an affi liate of Johnson & Johnson Innovation.


The fi ndings are published the journal Oncotarget. 28555pr@reply-direct.com


www.analytica.de


FORENSICS, Olympia, London 29–30 April 2014


Forensics Europe Expo, 29 - 30 April 2014 at Olympia, London, is your opportunity to grow your business and meet over 3,000 forensic buyers and specifiers.


The success of Forensics Europe Expo 2013 has established the event as the premier dedicated


international forum for the entire forensics sector and supply chain to meet and do business.


In 2013, Forensics Europe Expo delivered over 3000 buyers and specifiers to source innovative forensic products, equipment and services, as well as providing the definitive source of education, best practice, training and networking.


www.forensicseuropeexpo.com


Nanotubes Support Stem Cell Growth Researchers have found a new method for growing human


embryonic stem cells, that doesn’t rely on supporting human or animal cells.


The team of scientists led by the University of Surrey and in collaboration with Professor Peter Donovan at the University of California have developed a scaffold of carbon nanotubes upon which human stem cells can be grown into a variety of tissues. These new building blocks mimic the surface of the body’s natural support cells and act as scaffolding for stem cells to grow on. Cells that have previously relied on external living cells can now be grown safely in the laboratory, paving the way for revolutionary steps in replacing tissue after injury or disease.


Dr Alan Dalton, senior lecturer from the Department of Physics at the University of Surrey said: “While carbon nanotubes have been


used in the fi eld of biomedicine for some time, their use in human stem cell research has not previously been explored successfully.”


“Synthetic stem cell scaffolding has the potential to change the lives of thousands of people, suffering from diseases such as Parkinson’s, diabetes and heart disease, as well as vision and hearing loss. It could lead to cheaper transplant treatments and could potentially one day allow us to produce whole human organs without the need for donors.”


The research was funded by grants from the Human Frontier Science Program, Royal Society, Engineering and Physical Research Council, SETsquared and Beckman Coulter Inc.


Published in the journal Applied Materials & Interfaces 28556pr@reply-direct.com


HPLC 2014 New Orleans, USA 11-15 May 2014


http://hplc2014.org/


ELA 2014 Barcelona, Spain 13-15 May 2014


http://selectbiosciences.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96